Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.

Eve, Heather E

Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab. [electronic resource] - Leukemia & lymphoma Mar 2009 - 463-5 p. digital

Publication Type: Clinical Trial; Journal Article; Multicenter Study

1029-2403

10.1080/10428190802641979 doi


Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antigens, CD34
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cell Count
Cyclophosphamide--administration & dosage
Female
Hematopoietic Stem Cell Mobilization--methods
Humans
Lymphoma, Mantle-Cell--therapy
Male
Middle Aged
Rituximab
Vidarabine--administration & dosage